MetVital, Inc. Announces Collaboration with the National Institute of Neurological Disorders and Stroke (part of the NIH) in the Epilepsy Therapy Screening Program (ETSP)

SAN DIEGO, July 24, 2020 /PRNewswire/ -- MetVital, Inc., a privately held biopharmaceutical company developing small molecule modulators of altered glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial potential, today announces that the...

from PR Newswire: https://ift.tt/39rujcc